Could fewer HPV shots protect girls just as well?
NCT ID NCT06632912
First seen Jan 28, 2026 · Last updated May 05, 2026 · Updated 14 times
Summary
This study tests an experimental HPV vaccine in 1,800 females aged 9-35. It compares a 2-dose schedule for girls aged 9-14 against a 3-dose schedule for older girls and women. The goal is to see if fewer doses provide similar protection against HPV, a virus that can cause cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Daiyue District Center for Disease Control and Prevention
Tai’an, Shandong, China
-
Liaocheng Center for Disease Control and Prevention
Liaocheng, Shandong, China
-
Shanxian Center for Disease Control and Prevention
Heze, Shandong, China
Conditions
Explore the condition pages connected to this study.